A reduction in the anti-inflammatory cytokine IL-10, which regulates the release of pro-inflammatory cytokines and antigen presentation, has also been noted; thus, IL-10 is proposed as a potent anti-inflammatory biological therapy for IBS [96]. Here, IL10 is linked to irritable bowel syndrome.